title: Compartmentalized NMDA receptor signalling to survival and death.
abstract: The ability of Ca(2+) influx through the N-methyl d-aspartate subclass of glutamate receptor (NMDA receptor) to both kill neurons and to promote survival under different circumstances is well established. Here we discuss the signal pathways that mediate this dichotomous signalling, and the factors that influence whether an NMDA receptor-dependent Ca(2+) signal results in a net pro-survival or pro-death effect. The magnitude of NMDA receptor activation, be it intensity or duration, is of course very important in determining the nature of the response to an episode of NMDA receptor activity, with excitotoxic death pathways requiring higher levels than survival pathways. However, the NMDA receptor is not merely a conduit for Ca(2+) influx: the consequences of NMDA receptor activity can be influenced by signalling molecules that physically associate with the NMDA receptor or indeed the location (synaptic versus extrasynaptic) of the receptor. Furthermore, we discuss the possibility that the Ca(2+) effectors of survival and death are in different subcellular locations, and thus depend on the spatial characteristics of the Ca(2+) transient. A greater understanding of these issues may point to ways of selectively blocking pro-death signalling in neurological disorders such as stroke, where global NMDA receptor antagonists have proved ineffective.
authors: Centre for Neuroscience Research, University of Edinburgh, Edinburgh EH8 9XD, UK.
authors: Francesc X
authors: FX
authors: Soriano
authors: Giles E
authors: GE
authors: Hardingham
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D020013:Calcium Signaling / Q000187:drug effects; D002462:Cell Membrane / Q000378:metabolism; D002467:Cell Nucleus / Q000378:metabolism; D002470:Cell Survival; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008928:Mitochondria / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000378:metabolism*; D020521:Stroke / Q000188:drug therapy / Q000378:metabolism; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D018691:Excitatory Amino Acid Antagonists; D018696:Neuroprotective Agents; D016194:Receptors, N-Methyl-D-Aspartate
references: Nature. 1997 Jan 16;385(6613):260-5
references: 9000075
references: Science. 2001 Oct 12;294(5541):333-9
references: 11598293
references: Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12885-90
references: 11058158
references: Science. 1969 May 9;164(3880):719-21
references: 5778021
references: Neuron. 1999 Apr;22(4):789-98
references: 10230798
references: Biochem J. 1996 Sep 15;318 ( Pt 3):897-901
references: 8836135
references: Eur J Neurosci. 2002 Aug;16(4):575-83
references: 12270033
references: Lancet Neurol. 2002 Oct;1(6):383-6
references: 12849400
references: Curr Biol. 1998 Jun 4;8(12):692-9
references: 9637920
references: Neuron. 1995 Oct;15(4):961-73
references: 7576644
references: Nat Med. 1999 Mar;5(3):270-1
references: 10086378
references: Curr Opin Pharmacol. 2006 Feb;6(1):53-60
references: 16359918
references: J Physiol. 2006 May 1;572(Pt 3):789-98
references: 16513670
references: J Alzheimers Dis. 2006 Sep;10(1):81-7
references: 16988485
references: AMA Arch Ophthalmol. 1957 Aug;58(2):193-201
references: 13443577
references: Science. 1999 Jan 1;283(5398):70-4
references: 9872743
references: Cell Death Differ. 2002 Aug;9(8):818-31
references: 12107825
references: Nat Neurosci. 2001 Mar;4(3):261-7
references: 11224542
references: J Neurosci. 1993 May;13(5):2085-104
references: 8097530
references: Curr Mol Med. 2004 Mar;4(2):87-111
references: 15032707
references: Biochim Biophys Acta. 2002 Nov 4;1600(1-2):148-53
references: 12445470
references: Cell. 2005 Jan 28;120(2):275-85
references: 15680332
references: J Biol Chem. 1997 Nov 7;272(45):28183-6
references: 9353264
references: Science. 1993 Apr 9;260(5105):181-6
references: 8097060
references: Science. 2002 Oct 25;298(5594):846-50
references: 12399596
references: Nat Neurosci. 1998 Sep;1(5):366-73
references: 10196525
references: Curr Mol Med. 2004 Mar;4(2):149-77
references: 15032711
references: J Biol Chem. 2001 Feb 16;276(7):5256-64
references: 11054421
references: Trends Neurosci. 2003 Feb;26(2):81-9
references: 12536131
references: J Neurophysiol. 2006 Mar;95(3):1727-34
references: 16319212
references: Nature. 2000 Jan 20;403(6767):316-21
references: 10659851
references: Curr Top Med Chem. 2006;6(8):787-99
references: 16719817
references: Neurobiol Dis. 2004 Jul;16(2):440-53
references: 15193300
references: Neuron. 2002 Apr 11;34(2):235-44
references: 11970865
references: J Neurosci. 2005 Apr 27;25(17):4279-87
references: 15858054
references: N Engl J Med. 1994 Mar 3;330(9):613-22
references: 7905600
references: Neuron. 1998 Apr;20(4):727-40
references: 9581764
references: Mol Pharmacol. 2006 Sep;70(3):1022-32
references: 16778008
references: Nature. 1995 Dec 21-28;378(6559):785-9
references: 8524413
references: Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2808-13
references: 11226322
references: J Neurosci. 2006 Apr 26;26(17):4509-18
references: 16641230
references: Cell. 2004 Oct 1;119(1):61-74
references: 15454081
references: J Comp Neurol. 1994 Feb 22;340(4):551-65
references: 7911808
references: J Neurosci. 2006 Feb 1;26(5):1331-3
references: 16452656
references: Mol Cell Biol. 2001 Feb;21(3):893-901
references: 11154276
references: Cell Mol Life Sci. 2004 Mar;61(6):657-68
references: 15052409
references: J Neurosci. 2007 Mar 14;27(11):2846-57
references: 17360906
references: Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2508-13
references: 10051673
references: JAMA. 2001 Dec 5;286(21):2673-82
references: 11730442
references: J Neurochem. 2006 Sep;98(5):1646-56
references: 16923173
references: J Biol Chem. 1996 Dec 27;271(52):33161-4
references: 8969168
references: Biochem Soc Trans. 2006 Nov;34(Pt 5):936-8
references: 17052231
references: Cell. 1999 Mar 19;96(6):857-68
references: 10102273
references: J Neurosci. 2004 Dec 1;24(48):10858-67
references: 15574736
references: Nature. 2006 Aug 24;442(7105):929-33
references: 16906136
references: J Neurosci. 2007 Mar 28;27(13):3445-55
references: 17392461
references: Nat Neurosci. 2002 May;5(5):405-14
references: 11953750
references: Nat Neurosci. 2001 Jun;4(6):565-6
references: 11369935
references: Protein Sci. 1996 Jul;5(7):1215-28
references: 8819155
references: Arch Med Res. 2006 Jan;37(1):11-8
references: 16314180
references: Neuron. 2007 Feb 15;53(4):549-62
references: 17296556
references: Trends Neurosci. 1989 Jul;12(7):265-70
references: 2475939
references: Cell. 2003 Dec 26;115(7):863-77
references: 14697204
references: J Neurosci. 2004 Oct 20;24(42):9441-50
references: 15496680